Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Aug 4;95(16):9558-61.
doi: 10.1073/pnas.95.16.9558.

Protection against lipoapoptosis of beta cells through leptin-dependent maintenance of Bcl-2 expression

Affiliations

Protection against lipoapoptosis of beta cells through leptin-dependent maintenance of Bcl-2 expression

M Shimabukuro et al. Proc Natl Acad Sci U S A. .

Abstract

Obesity causes its complications through functional and morphologic damage to remotely situated tissues via undetermined mechanisms. In one rodent model of obesity, the Zucker diabetic fatty fa/fa rat, overaccumulation of triglycerides in the pancreatic islets may be responsible for a gradual depletion of beta cells, leading to the most common complication of obesity, non-insulin-dependent diabetes mellitus. At the onset of non-insulin-dependent diabetes mellitus, the islets from fa/fa rats contain up to 100 times the fat content of islets from normal lean rats. Ultimately, about 75% of the beta cells disappear from these fat-laden islets as a consequence of apoptosis induced by long-chain fatty acids (FA). Here we quantify Bcl-2, the anti-apoptosis factor in these islets, and find that Bcl-2 mRNA and protein are, respectively, 85% and 70% below controls. In normal islets cultured in 1 mM FA, Bcl-2 mRNA declined by 68% and completely disappeared in fa/fa islets cultured in FA. In both groups, suppression was completely blocked by the fatty acyl-CoA synthetase inhibitor, triacsin C, evidence of its mediation by fatty acyl-CoA. To determine whether leptin action blocked FA-induced apoptosis, we cultured normal and fa/fa islets in 1 mM FA with or without leptin. Leptin completely blocked FA-induced Bcl-2 suppression in normal islets but had no effect on islets from fa/fa rats, which are unresponsive to leptin because of a mutation in their leptin receptors (OB-R). However, when wild-type OB-R is overexpressed in fa/fa islets, leptin completely prevented FA-induced Bcl-2 suppression and DNA fragmentation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Bcl-2 and Bax expression in pancreatic islets of lean wild type (+/+) ZDF or obese (fa/fa) ZDF rats. (A) Representative Southern blot of Bcl-2 RT-PCR products. (B) Immunoblot of Bcl-2. (C) Representative Southern blot of Bax RT-PCR products. Bars represent the mean ± SEM of Bcl-2/β-actin (n = 3) or Bax/β-actin ratios (A and C) or arbitrary densitometric unit (B) (n = 3). ∗, P < 0.01 vs. +/+ values.
Figure 2
Figure 2
(A) Effect of FA on Bcl-2 mRNA in pancreatic islets from +/+ and obese homozygous (fa/fa) ZDF rats. (B) The effect of 10 μM triacsin C on the Bcl-2-lowering action of FA in islets of +/+ and fa/fa ZDF rats.
Figure 3
Figure 3
Effect of 1 mM FA alone or in the presence of recombinant leptin on Bcl-2 mRNA in islets from 7-week-old +/+ or fa/fa ZDF rats. Bars represent the mean ± SEM of the Bcl-2/β-actin mRNA ratio. ∗, P < 0.01 vs. 0 mM FA; †, P < 0.01 vs. 1 mM FA.
Figure 4
Figure 4
Effects of overexpressing OB-Rb or, as a control, β-gal in pancreatic islets of 10-week-old obese fa/fa ZDF rats. (A) Expression of OB-Rb mRNA by RT-PCR and protein by immunoblotting. (B) Effects of 20 ng/ml recombinant leptin on Bcl-2 mRNA levels in islets cultured for 24 h with 1 mM FA. Bars represent the mean ± SEM of the Bcl-2/β-actin mRNA ratio. ∗, P < 0.01 vs. 0 mM FFA; †, P < 0.01 vs. 1 mM FA. (C) Effect of 20 ng/ml recombinant leptin on DNA fragmentation in pancreatic islets for 24 h with 1 mM FA. DNA laddering as a percentage of total DNA is indicated by the numbers.

Similar articles

Cited by

References

    1. Lee Y, Hirose H, Ohneda M, Johnson J H, McGarry J D, Unger R H. Proc Natl Acad Sci USA. 1994;91:10878–10882. - PMC - PubMed
    1. Lee Y, Hirose H, Zhou Y-T, Esser V, McGarry J D, Unger R H. Diabetes. 1997;46:408–413. - PubMed
    1. Ohneda M, Inman L R, Unger R H. Diabetologia. 1995;38:173–179. - PubMed
    1. Shimabukuro M, Zhou Y-T, Levi M, Unger R H. Proc Natl Acad Sci USA. 1998;95:2498–2502. - PMC - PubMed
    1. Shimabukuro M, Ohneda M, Lee Y, Unger R H. J Clin Invest. 1997;100:290–295. - PMC - PubMed

Publication types

LinkOut - more resources